64results about How to "Clear treatment effect" patented technology

The invention belongs to the field of medicine, and in particular relates to a pharmaceutical composition for treating bedsore and a preparation method thereof. The pharmaceutical composition provided by the invention comprises the following crude medicines in parts by weight: 30-70 parts of rhizoma bletillae, 20-40 parts of kuh-seng, 20-40 parts of Chinese waxgourd peel, 20-40 parts of job's-tears seed, 5-30 parts of armand clematis stem, 5-30 parts of dried ginger, 10-50 parts of honeycomb, 5-30 parts of pepper, 5-30 parts of chilli, 10-50 parts of catechu, 10-40 parts of atractylodes rhizome, 20-80 parts of red halloysite, 10-60 parts of gallnut, 10-40 parts of chuanxiong rhizome and 5-40 parts of Japanese ampelopsis root. The pharmaceutical composition achieves the purpose of treating bedsore by sterilizing, promoting diuresis, detoxicating and promoting tissue regeneration, and the pharmaceutical composition has definite, stable and controllable curative effects on treating bedsore.

The invention specifically relates to a pharmaceutical composition for treating thrombocytopenia, and a preparation method and application thereof, belonging to the field of Chinese medicines. The invention provides a novel pharmaceutical composition for treating thrombocytopenia, and the pharmaceutical composition is prepared from the raw materials of hairyvein agrimony, cortex moutan radicis, gentrin knotweed, glutinous rehmannia, radix astragali, cape jasmine and pseudo-ginseng, has the functions of nourishing yin, tonifying blood, clearing heat and cooling the blood, and can be used for patients who suffer from bleeding, thrombocytopenia and the like caused by deficiency of yin and hot blood. Application of the pharmaceutical composition enables the purpose of the treating thrombocytopenia to be realized.

The invention belongs to the medicine field, particularly relates to a pharmaceutical composite for curing colon cancer and a preparing method thereof. The technical problem solved by the invention is to provide a brand-new pharmaceutical composite for curing colon cancer and a preparation method thereof. The pharmaceutical composition comprises the following components: 5-11 parts of rucea javanica, 5-11 parts of common camptotheca fruit, 8-16 parts of semen coicis and/or sargentgloryvinestem, 8-16 parts of curcumaaromaticaSalisb, and 5-16 parts of gingseng and/or campanumaea pilosula. The pharmaceutical composition has efficacies of clearing away heat and toxic material, activating blood circulation, removing masses, benefiting vital energy and strengthening healthy energy and the like.Long-term clinic observation and series of experimental researches show that the pharmaceutical composition has good anti-cancer effect, especially has obvious curative effect. The parasitical composition mainly cures patients of colon cancer suffering from toxin and phlegm internal resistance and qi deficiency, has the symptoms of abdominal pain, fixed pain spot, unpalpable pain, abdominalmass, abdominal distention, acratia, anorexia, dark-purple tongue or tongue with blockage points or ecchymosises, white and greasy tongue coat, and pulse fine tart, and is used by patients of colon cancer or colon cancer postoperation dialectical species suffering from toxin and phlegm internal resistance and qi deficiency.

The invention relates to a preparation method of a flavonoid medicine for treating frostbite, which comprises the following steps: weighting fresh nanking cherry, washing and crushing, removing the shell to obtain a basic solution, adding 75% of ethanol containing 1% of hydrochloric acid with volume ratio of 1:4, wherein the ultrasonic frequency is 40KHz, extracting for 10-60 minutes, performing backflow extraction for 1-6 hours, performing pressure reduction and concentrating to alcohol amount at 75%, then standing away from light for 6-18 hours and filtering the deposition, and placing a filtrate in a rotary evaporation instrument for performing pressure reduction and concentrating to a dry state, suspending a concentrate and dispersing in water, filtering to remove an insoluble substance, filling the filtrate in a polyamide column, adding water with 30 times amount of polyamide for eluting, removing an eluate, adding 90% of ethanol for eluting to make the eluate transparent, collecting the eluate and performing pressure reduction and concentrating, and performing vacuum freeze drying on a concentrate to obtain the flavonoid medicine. The flavonoid medicine for treating frostbite has the characteristics of single component, definite therapeutic effect and convenient usage.

The invention relates to a Chinese traditional medical compound for curing fracture, boon stump and injury of tendon and muscle and haemostasis. The invention is made of the raw materials by weight proportion and carriers which are acceptable on pharmacy of radix astragali, radix codonopsis pilosulae, tail of angelica, cortex periplocae, szechuan lovage rhizome, safflower, red paeony root, eucommia ulmoides, rhizome drynaria, diverse wormwood herb, cassia twig, medicinal cyathula root and pawpaw. The invention having the advantages of rational components and obvious curing effect can greatly decrease the pain of patients due to the fracture.

The invention relates to a clindamycin phosphate vaginal sustained-release gel and its preparation method. The clindamycin phosphate vaginal sustained-release gel comprises the following components of: by weight, 1-5% of clindamycin phosphate, 5-15% of poloxamer (188), 8-20% of poloxamer (407), 0.5-2% of sodium carboxymethyl cellulose, 0.05-2% of carbomer (980), 0.02-5% of an additive and the balance being water. The clindamycin phosphate vaginal sustained-release gel provided by the invention has advantages of clear curative effect, long detention time in vagina, sustained release of the drug effect, long onset time and good compliance of patients.

The invention belongs to the field of tumor information processing, and provides a whole-course supervision system and method for soft tissue tumor informatization pathology auxiliary diagnosis. The system comprises: a clinical data management platform in which clinical data of soft tissue tumors and expression profiles or/and characteristic spectra of different types of soft tissue tumors at different levels are pre-stored; a pathological diagnosis data platform which is used for receiving clinical data, pathological histological images, immunohistochemical results and molecular genetics results of patients to form expression profiles or/and characteristic spectra of different levels, comparing the expression profiles or/and characteristic spectra with the expression profiles or/and characteristic spectra of corresponding levels in the clinical data management platform, determining the same tumor type determined at different levels as a final pathological diagnosis type, and generating a standardized diagnosis report; and a prognosis data information platform which is used for evaluating prognosis risk factors and feeding back the prognosis risk factors to the pathological diagnosis data platform, establishing a clinical prediction model, evaluating the survival rate, regularly prompting follow-up visit patient time and content, and recording follow-up visit information.

The invention discloses an application of thyme compound plant essential oil in preventing necrotic enteritis. The plant essential oil contains thyme-nutmeg compound essential oil and thyme-basil compound essential oil. An applicator is successful in constructing an animal model with necrotic enteritis through 1-2 years. For the model, wheat basal feed is used for feeding, and fish meal is added at the later period; clostridium perfringens is adopted for independently attacking toxicity, and the classic lesions is obvious; and the phenomenon of mixing of a previous coccidium concurrent model and coccidiosis can be eliminated. The application disclosed by the invention has the advantages that the test period is short and the repeatability is high. In addition to an in-vitro experiment, the applicator also utilizes the model to study the in-vivo control effect of the plant essential oil to really define the preventing and treating effects of the plant essential oil for the necrotic enteritis.

The invention discloses application of a PC2 gene or a recombinant virus expressing the PC2 gene to preparation of a medicament for treating osteoarthritis. The invention provides application of the PC2 gene to the preparation of a medicament for treating osteoarthritis. The PC2 gene is a gene coded with a PC2 protein.The PC2 protein is a protein consists of an amino acid sequence shown as a sequence 1 in a sequence table. As proved by the inventor of the invention, the PC2 gene has a definite treatment effect on osteoarthritis, so that a new thought is provided for the development of a gene applied to osteoarthritis treatment, and the selection range of clinical gene treatment is enlarged. The PC2 gene has important application and popularization value.

The invention discloses an application of mutmeng essential oil and basil essential oil to prevent necrotic enteritis. Plant essential oil includes mutmeng pure essential oil, basil pure essential oil or mutmeng-basil compound essential oil. The applicant spends one to two years and successfully builds an animal model of the necrotic enteritis. The model is feed with wheat basal diet, and fish meal is added in a later period; clostridium perfringens is adopted to counteract toxic substances independently, and typical pathological changes are obvious; and the previous phenomenon that a coccidium concurrent model and coccidiosis are confused can be excluded. The experiment period is short, and the repeatability is high. In addition to in-vitro experiments, the applicant also takes use of the model to do research on the in-vivo control effect of the plant essential oil, and it is really clear that the plant essential oil has the effects of preventing and curing the necrotic enteritis.

The invention discloses a medicine composition for treating prostatitis. The medicine composition is prepared from the following raw material medicines in parts by weight: 28-32 parts of herba leonuri, 13-17 parts of rhizoma polygoni cuspidati, 10-14 parts of cortex phellodendri and 1-7 parts of cinnamon. The medicine disclosed by the invention can obviously improve the indexes of prostatitis, is used for treating chronic prostatitis, and has relatively great values in practical application.

The invention discloses a Chinese medicinal compound for treating insomnia in female climacteric, which consists of the following components by weight: 30g of glossy privet fruit, 15g of eclipta alba, 30g of raw astragalus, 15g of radix pseudostellariae, 15g of roasted bighead atractylodes rhizome, 20g of Chinese angelica, 30g of raw oyster, 30g of spina date seed, 20g of white peony root, 12g of thinleaf milkwort root bark, 20g of red-rooted salvia root, and 6g of costustoot. According to the Chinese medicinal compound, the sleeping situation of a patient suffering insomnia in climacteric can be remarkably improved. The Chinese medicinal compound is used for treating both heart and kidney, regulating qi and blood and restoring normal coordination between heart and kidney, and has an exact treatment effect to insomnia in climacteric.

The invention provides a gynecological health caring and face nourishing compound. The compound is any dosage form mainly made from coix seeds, dahurian angelica root, lily, parched hawthorn fruit, raspberry and Radix Puerariae through a conventional method of traditional Chinese medicine pharmacy. Clinical and experimental data prove that the compound has very good conditioning and health caring effects on female irregular menstruation, uterine fibroids and uterine, has specific maintaining and health caring effects on problems of women's ovaries and ovarian appendage, has an excellent conditioning effect on women's leucorrhea, has very good softening and eliminating effects on women's breast hyperplasia and breast cysts, has specific breast enlarging, breast strengthening, breast lifting and breast beautifying effects, and has specific alleviation and treatment effects on female skin appearance premature aging, chloasma, acnes, chronic facial recurrent dermatitis and skin dry syndromes.

The invention relates to a traditional Chinese medicine preparation, and discloses a traditional Chinese medicine composition for treating vascular dementia, which comprises the following raw medicinal materials: polygala tenuifolia, storax, hippocampus, lycopodium clavatum, turtle shell, scalded rhizoma cibotii, caulis spatholobi, vine of multiflower knotweed, rhizoma atractylodis, cimicifugae foetidae and pomegranate seed. Wherein the content of the radix polygalae is 5 to 15 parts by weight, the content of the storax is 0.3 to 1 part by weight, the content of the sea horse is 3 to 9 parts by weight, the content of the lycopodium clavatum is 3 to 15 parts by weight, the content of the turtle shell is 9 to 30 parts by weight, the content of the hot rhizoma cibotii is 6 to 15 parts by weight, the content of the caulis spatholobi is 9 to 15 parts by weight, the content of the caulis polygoni multiflori is 9 to 15 parts by weight, and the content of the rhizoma atractylodis is 3 to 12 parts by weight. The content of the rhizoma cimicifugae is 3-15 parts by weight, and the content of the pomegranate seeds is 5-15 parts by weight. The traditional Chinese medicine composition for treating vascular dementia has the effects of tonifying the kidney, nourishing blood, reducing phlegm, dredging collaterals, soothing the nerves and promoting intelligence, and can be used for treating vascular dementia, improving the cognitive ability of patients and improving dementia symptoms. The invention also provides a medicinal preparation for treating vascular dementia.